China NT Pharma Group Company Limited provided consolidated earnings guidance for the year ended December 31, 2015. The group expects to record a substantial increase in net profit by more than 40 times for the year ended December 31, 2015 as compared to the year ended December 31, 2014. Such increase is primarily attributable to the significant improvement of gross profit margin of its proprietary products and decrease of finance cost.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.023 HKD | -4.17% | -7.69% | -56.36% |
03-28 | China NT Pharma Group Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
01-15 | China NT Pharma Group Company Limited Announces Directorate Changes | CI |
1st Jan change | Capi. | |
---|---|---|
-56.36% | 8.12M | |
+18.70% | 22.46B | |
+18.55% | 15.04B | |
+18.94% | 13.98B | |
+56.80% | 13.15B | |
-9.56% | 6.89B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+13.66% | 5.71B | |
+4.00% | 4.69B |
- Stock Market
- Equities
- 1011 Stock
- News China NT Pharma Group Company Limited
- China NT Pharma Group Company Limited Provides Consolidated Earnings Guidance for the Year Ended December 31, 2015